全髋关节置换术治疗的终末期髋骨关节炎的遗传风险因素:全基因组关联研究
复合遗传因素的OR为1.04(P<.001),低于年龄(OR 2.38;P<.001)和BMI(OR 1.81;P<.001)的效应。
要点
- 识别出13个与终末期髋骨关节炎相关的显著基因,包括5个新位点。
- 复合遗传因素OR为1.04(P<.001),效应低于年龄和BMI。
- 年龄OR为2.38(P<.001),BMI OR为1.81(P<.001),均高于遗传因素。
核心结论
- 多个遗传变异(包括5个新位点)与因原发性全髋关节置换术治疗的终末期髋骨关节炎相关。
- 年龄和BMI与终末期疾病风险升高的关联大于遗传因素。
研究设计与样本
- 全基因组关联研究,患者来自国家患者数据仓库,通过行政编码识别因髋骨关节炎行初次全髋关节置换术者。
- 对基因型数据进行全基因组回归,校正年龄、性别和体重指数(BMI)。
- 采用多变量逻辑回归模型评估已识别遗传变异的复合遗传风险。
主要发现
- 共识别出13个显著基因。
- 复合遗传因素导致终末期髋骨关节炎的OR为1.04(P<.001)。
- 年龄的OR为2.38(P<.001),BMI的OR为1.81(P<.001),遗传效应低于年龄和BMI。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although a genetic component to hip osteoarthritis (OA) has been described, focused evaluation of the genetic components of end-stage disease is limited. We present a genomewide association study for patients undergoing total hip arthroplasty (THA) to characterize the genetic risk factors associated with end-stage hip osteoarthritis (ESHO), defined as utilization of the procedure. METHODS: Patients who underwent primary THA for hip OA were identified in a national patient data repository using administrative codes. Fifteen thousand three hundred and fifty-five patients with ESHO and 374,193 control patients were identified. Whole genome regression of genotypic data for patients who underwent primary THA for hip OA corrected for age, sex, and body mass index (BMI) was performed. Multivariate logistic regression models were used to evaluate the composite genetic risk from the identified genetic variants. RESULTS: There were 13 significant genes identified. Composite genetic factors resulted in an odds ratio 1.04 for ESHO (P < .001). The effect of genetics was lower than that of age (Odds Ratio (OR): 2.38; P < .001) and BMI (1.81; P < .001). CONCLUSION: Multiple genetic variants, including 5 novel loci, were associated with end-stage hip OA treated with primary THA. Age and BMI were associated with greater odds of developing end-stage disease when compared to genetic factors.
引用
- Kulm S, Kaidi AC, Kolin D, et al. Genetic Risk Factors for End-Stage Hip Osteoarthritis Treated With Total Hip Arthroplasty: A Genome-wide Association Study. J Arthroplasty. 2023. PMID: 37179025. doi:10.1016/j.arth.2023.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。